A population-based case-control teratologic study of oral erythromycin treatment during pregnancy

Reproductive Toxicology

Volumn 13, Issue 6, 1999, Pages 531-536

  Czeizel, Andrew E ^a   Rockenbauer, Magda ^a   Sørensen, Henrik T ^b   Olsen, Jørn ^b  

^a FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

^b UNIVERSITY OF AARHUS   (Denmark)

Author keywords

Case control analysis; Congenital abnormalities; Erythromycin; Human teratogenic potential

Indexed keywords

ERYTHROMYCIN; MACROLIDE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; FEMALE; FETUS; FETUS RISK; FIRST TRIMESTER PREGNANCY; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; NEWBORN; PREGNANCY; PRENATAL DISORDER; REGISTER; TERATOGENESIS; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; ERYTHROMYCIN; FEMALE; HUMANS; HUNGARY; INFANT, NEWBORN; PREGNANCY; REGISTRIES;

EID: 0033226610     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(99)00046-5     Document Type: Article

References (25)

1. Czeizel A.E., Rockenbauer M., Olsen J. Use of antibiotics during pregnancy. Eur J Obstet Gynec Reprod Biol. 81:1998;1-8.
2. Philipson A., Sabath L.D., Charles D. Erythromycin and clindamycin absorption and elimination in pregnant women. Clin Pharmacol Ther. 19:1976;68-77.
3. Heilman F.R., Herrell W.E., Wellman W.E., Geraci J.E. Some laboratory and clinical observations on a new antibiotic, erythromycin (Ilotycin). Proc Staff Meet Mayo Clin. 27:1952;285-304.
4. Kiefer L., Rubin A., McCoy J.B., Foltz E.L. The placental transfer of erythromycin. Am J Obstet Gynecol. 69:1955;174-177.
5. Philipson A., Sabath L.D., Charles D. Transplacental passage of erythromycin and clindamycin. N Engl J Med. 288:1973;1219-1220.
6. Fenton L.J., Light L.J. Congenital syphilis after maternal treatment with erythromycin. Obstet Gynecol. 47:1976;492-494.
7. Friedman J.M., Polifka J.E. The Effects of Drugs on the Fetus and Nursing Infant. 1996;Johns Hopkins Univ. Press, Baltimore.
8. Czeizel A.E., Rácz J. Evaluation of drug intake during pregnancy in the Hungarian case-control surveillance of congenital anomalies. Teratology. 42:1990;505-512.
9. Czeizel A.E. The first 25 years of the Hungarian congenital abnormality registry. Teratology. 55:1997;299-305.
10. Czeizel A.E. The role of pharmacoepidemiology in pharmacovigilance rational drug use in pregnancy . Pharmacoepid Drug Safety. 8:1999;S55-S61.
11. Periti P., Mazzei T., Mini E., Novelli A. Pharmacokinetic drug interactions of macrolids. Clin Pharmacokinet. 23:1992;106-131.
12. Stata Corp. STATA Statistical Software: Release 4.0 for Windows Stata Corporation. College Station. Texas, 1997.
13. Källen B. Epidemiology of Human Reproduction. CRC Press: Boca Raton, Florida, 1988.
14. Czeizel AE, Telegdi L, Tusnády G. Multiple Congenital Abnormalities. Akadémiai Kiadó: Budapest, 1998.
15. Khoury M.J., James L.M., Flanders W.D., Erickson J.D. Interpretation of recurring weak associations obtained from epidemiological studies of suspected human teratogens. Teratology. 46:1992;69-77.
16. Jaffe P., Liberman M.M., McFadyen I., Valman H.B. Incidence of congenital limb-reduction deformities. Lancet. 1:1975;526-527.
17. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Publishing Sciences Group Inc.:Littleton, Mass.; 1977.
18. Jick H., Holmes L.B., Hunter J.R., et al. First-trimester drug use and congenital disorders. JAMA. 246:1981;343-346.
19. Aselton P., Jick H., Milunsky A., et al. First-trimester drug use and congenital disorders. Obstet Gynecol. 65:1985;451-455.
20. Briggs G.G., Freeman R.K., Yaffe S.J. Drugs in Pregnancy and Lactation. 5th ed. 1998;Williams and Wilkins, Baltimore.
21. McCormack W.M., Rosner B., Lee Y.-H., et al. Effect on birth weight of erythromycin treatment of pregnant women. Obstet Gynecol. 69:1987;202-207.
22. Mercer B.M., Moretti M.L., Prevost R.R., Sibai B.M. Erythromycin therapy in preterm premature rupture of the membranes A prospective, randomized trial of 220 patients . Am J Obstet Gynecol. 166:1992;794-802.
23. Romero R., Sibai B., Caritis S., et al. Antibiotic treatment of preterm labor with intact membranes a multicenter, randomized, double-blinded, placebo-controlled trial . Am J Obstet Gynecol. 169:1993;764-774.
24. Moriguchi M., Fujita M., Koeda T. Teratological studies on SF-837 in mice. Jpn J Antibiot. 25:1972;193-198.
25. Moriguchi M., Fujita M., Koeda T. Teratological studies on SF-837 in rats. Jpn J Antibiot. 25:1972;187-192.